PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8+ T Cell Responses

Jun Wang1,2, Yue Li1, Yan Shen1

  • 1Department of Medical Microbiology and Parasitology, Fourth Military Medical University, Xi'an, China.

Frontiers in Immunology
|January 30, 2019
PubMed

Insights

Programmed death-1 (PD-1) pathway modulation using PDL1-IgG1Fc protein offers a promising strategy to combat lethal cerebral malaria (CM). This treatment protects the brain by regulating CD8+ T cells and macrophages, improving survival in experimental models.

Area of Science:

  • Immunology
  • Neuroscience
  • Infectious Diseases

Background:

  • Cerebral malaria (CM), primarily caused by Plasmodium falciparum, is a life-threatening complication of severe malaria.
  • Pathogenesis of CM involves immunopathology driven by CD8+ T cells infiltrating the brain, necessitating novel therapeutic strategies.
  • The programmed death-1 (PD-1) pathway is a key regulator of immune responses and a potential therapeutic target.

Purpose of the Study:

  • To investigate the therapeutic potential of soluble fusion proteins, PDL1-IgG1Fc and PDL2-IgG1Fc, for treating CM.
  • To evaluate the role of the PD-1/PDL signaling pathway in CM pathogenesis and host protection.
  • To assess the impact of PDL1-IgG1Fc on immune cell function and blood-brain barrier integrity during experimental CM (ECM).

Main Methods:

  • Construction of soluble fusion proteins: PDL1-IgG1Fc and PDL2-IgG1Fc.
  • Utilized PD-1-deficient (Pdcd1-/-) and wild-type (WT) mice to study PD-1 pathway function.
  • Administered PDL1-IgG1Fc to mice during experimental cerebral malaria (ECM) and assessed survival, immune cell activity, and blood-brain barrier integrity.

Main Results:

  • PD-1 pathway deficiency resulted in increased CD8+ T cell proliferation and reduced survival in mice.
  • Treatment with PDL1-IgG1Fc significantly prolonged survival in mice with experimental CM (ECM).
  • PDL1-IgG1Fc ameliorated blood-brain barrier disruption by suppressing CD8+ T cell cytotoxicity and M1 polarization of macrophages.

Conclusions:

  • Enhancing PD-1/PDL signaling via PDL1-IgG1Fc administration is a promising strategy for protecting against CM.
  • Early-stage intervention with PDL1-IgG1Fc helps maintain immune homeostasis in the brain during ECM.
  • PDL1-IgG1Fc demonstrates potential as a future therapeutic candidate for cerebral malaria treatment.

Related Concept Videos

Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
8.5K
Nuclear Fusion02:45

Nuclear Fusion

The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.8K
Repressed Memory01:16

Repressed Memory

Repressed memories are a psychological phenomenon where memories of traumatic events are unconsciously blocked from a person's awareness. This process occurs as a defense mechanism, protecting the mind from the emotional impact of distressing or painful experiences. For example, a person who has experienced childhood trauma may grow up with no conscious recollection of the event. In such cases, the memories are thought to be buried deep within the subconscious, inaccessible to the conscious...
515
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.4K
Repressible Operon: trp Operon01:21

Repressible Operon: trp Operon

The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
1.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.0K